PRO-DEX, INC. Long-Term Debt, Maturity, after Year Five
PRO-DEX, INC. (PDEX) had Long-Term Debt, Maturity, after Year Five of $3.21 million as of 2025-06-30, per its 10-K filed 2025-09-04.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2025-09-04
- 2025-06-30: Long-Term Debt, Maturity, after Year Five $3.21M.
- 2024-06-30: Long-Term Debt, Maturity, after Year Five $3.46M.
- 2023-06-30: Long-Term Debt, Maturity, after Year Five $3.69M.
- 2022-06-30: Long-Term Debt, Maturity, after Year Five $4.60M.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2025-06-30 | $3.21M 10-K · filed 2025-09-04 |
| 2024-06-30 | $3.46M 10-K · filed 2024-09-05 |
| 2023-06-30 | $3.69M 10-K · filed 2023-10-13 |
| 2022-06-30 | $4.60M 10-K · filed 2022-09-08 |
| 2021-06-30 | $6.09M 10-K · filed 2021-09-09 |
| 2020-06-30 | $284.00K 10-K · filed 2020-09-10 |
| 2019-06-30 | $1.11M 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |